Global (United States, European Union and China) Opioid Induced Constipation (OIC) Drug Market Research Report 2019-2025
SKU ID :QYR-13829015 | Published Date: 23-Aug-2019 | No. of pages: 121Description
TOC
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type (2019-2025)
1.3.2 Lubiprostone
1.3.3 Methyl Naltrexone Bromide
1.3.4 Naldemedine
1.3.5 Alvimopan
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation (OIC) Drug Market Size
2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2014-2025
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2014-2025
2.2 Opioid Induced Constipation (OIC) Drug Growth Rate by Regions
2.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2014-2019
2.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers 2014-2019
3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI)
3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers
3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
3.6 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Lubiprostone Sales and Revenue (2014-2019)
4.1.2 Methyl Naltrexone Bromide Sales and Revenue (2014-2019)
4.1.3 Naldemedine Sales and Revenue (2014-2019)
4.1.4 Alvimopan Sales and Revenue (2014-2019)
4.1.5 Other Sales and Revenue (2014-2019)
4.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type
4.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type
4.4 Opioid Induced Constipation (OIC) Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Opioid Induced Constipation (OIC) Drug Sales by Application
6 United States
6.1 United States Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
6.2 United States Opioid Induced Constipation (OIC) Drug Breakdown Data by Type
6.3 United States Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
7 European Union
7.1 European Union Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
7.2 European Union Opioid Induced Constipation (OIC) Drug Breakdown Data by Type
7.3 European Union Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
8 China
8.1 China Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
8.2 China Opioid Induced Constipation (OIC) Drug Breakdown Data by Type
8.3 China Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
9.2 Rest of World Opioid Induced Constipation (OIC) Drug Breakdown Data by Type
9.3 Rest of World Opioid Induced Constipation (OIC) Drug Breakdown Data by Application
9.4 Rest of World Opioid Induced Constipation (OIC) Drug Breakdown Data by Countries
9.4.1 Rest of World Opioid Induced Constipation (OIC) Drug Sales by Countries
9.4.2 Rest of World Opioid Induced Constipation (OIC) Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Ironwood Pharmaceuticals
10.1.1 Ironwood Pharmaceuticals Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.1.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.1.5 Ironwood Pharmaceuticals Recent Development
10.2 Daiichi Sankyo Co
10.2.1 Daiichi Sankyo Co Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.2.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.2.5 Daiichi Sankyo Co Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.3.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.3.5 Pfizer Recent Development
10.4 Progenics Pharmaceuticals
10.4.1 Progenics Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.4.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.4.5 Progenics Pharmaceuticals Recent Development
10.5 Shionogi &
10.5.1 Shionogi & Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.5.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.5.5 Shionogi & Recent Development
10.6 Allergan
10.6.1 Allergan Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.6.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.6.5 Allergan Recent Development
10.7 Nektar Therapeutics
10.7.1 Nektar Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.7.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.7.5 Nektar Therapeutics Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.8.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.8.5 Purdue Pharma Recent Development
10.9 S.L.A. Pharma
10.9.1 S.L.A. Pharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.9.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.9.5 S.L.A. Pharma Recent Development
10.10 Mundipharma International Limited
10.10.1 Mundipharma International Limited Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Opioid Induced Constipation (OIC) Drug
10.10.4 Opioid Induced Constipation (OIC) Drug Product Introduction
10.10.5 Mundipharma International Limited Recent Development
10.11 Ono Pharmaceutical
10.12 Takeda Pharmaceutical Company Limited
10.13 Theravance Biopharma
10.14 Valeant Pharmaceuticals International
10.15 Cosmo Pharmaceuticals SA
10.16 Daewoong Pharmaceutical
10.17 C.B. Fleet Company
10.18 Sucampo Pharmaceuticals
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Opioid Induced Constipation (OIC) Drug Sales Channels
11.2.2 Opioid Induced Constipation (OIC) Drug Distributors
11.3 Opioid Induced Constipation (OIC) Drug Customers
12 Market Forecast
12.1 Global Opioid Induced Constipation (OIC) Drug Sales and Revenue Forecast 2019-2025
12.2 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type
12.3 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application
12.4 Opioid Induced Constipation (OIC) Drug Forecast by Regions
12.4.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025
12.4.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Opioid Induced Constipation (OIC) Drug Product Picture
Table Opioid Induced Constipation (OIC) Drug Key Market Segments
Table Major Manufacturers Opioid Induced Constipation (OIC) Drug Covered in This Report
Table Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Shar by Type 2014-2025
Figure Lubiprostone Figures
Table Major Manufacturers of Lubiprostone
Figure Methyl Naltrexone Bromide Figures
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Naldemedine Figures
Table Major Manufacturers of Naldemedine
Figure Alvimopan Figures
Table Major Manufacturers of Alvimopan
Figure Other Figures
Table Major Manufacturers of Other
Table Global Opioid Induced Constipation (OIC) Drug Market Share by Application 2019-2025 (K Units)
Figure Hospital Pharmacies Use Case
Figure Retail Pharmacies Use Case
Figure Online Pharmacies Use Case
Figure Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure Global Opioid Induced Constipation (OIC) Drug Market Size 2014-2025 (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales 2014-2019 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2014-2019 (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions in 2019
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions 2014-2019
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2019
Table Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2014-2019)
Figure Opioid Induced Constipation (OIC) Drug Value Share by Manufacturers in 2019
Table Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2014-2019) (USD/Unit)
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Plants/Factories Distribution
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Area Served
Table Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
Table Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Lubiprostone Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Methyl Naltrexone Bromide Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Naldemedine Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Alvimopan Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Other Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Type (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2018
Table Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2014-2019) (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2014-2019)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2018
Table Opioid Induced Constipation (OIC) Drug Price by Type 2014-2019 (USD/Unit)
Table Global Opioid Induced Constipation (OIC) Drug Sales by Application (2014-2019) (K Units)
Table Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2014-2019)
Figure Global Sales Opioid Induced Constipation (OIC) Drug Market Share by Application (2014-2019)
Figure United States Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table United States Opioid Induced Constipation (OIC) Drug Sales by Company (2014-2019) (K Units)
Table United States Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2014-2019)
Figure United States Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2019
Table United States Opioid Induced Constipation (OIC) Drug Sales by Type (2014-2019) (K Units)
Table United States Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2014-2019)
Figure United States Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Table United States Opioid Induced Constipation (OIC) Drug Sales by Application (2014-2019) (K Units)
Table United States Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2014-2019)
Figure United States Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure European Union Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure European Union Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Opioid Induced Constipation (OIC) Drug Sales by Company (2014-2019) (K Units)
Table European Union Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2014-2019)
Figure European Union Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2019
Table European Union Opioid Induced Constipation (OIC) Drug Sales by Type (2014-2019) (K Units)
Table European Union Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2014-2019)
Figure 2018 European Union Opioid Induced Constipation (OIC) Drug Market Share by Type
Table European Union Opioid Induced Constipation (OIC) Drug Sales by Application (2014-2019) (K Units)
Table European Union Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2014-2019)
Figure 2018 European Union Opioid Induced Constipation (OIC) Drug Market Share by Application
Figure China Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table China Opioid Induced Constipation (OIC) Drug Sales by Company (2014-2019) (K Units)
Table China Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2014-2019)
Figure China Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2019
Table China Opioid Induced Constipation (OIC) Drug Sales by Type (2014-2019) (K Units)
Table China Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2014-2019)
Figure China Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Table China Opioid Induced Constipation (OIC) Drug Sales by Application (2014-2019) (K Units)
Table China Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2014-2019)
Figure China Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Figure Rest of World Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales by Company (2014-2019) (K Units)
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2014-2019)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2019
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales by Type (2014-2019) (K Units)
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2014-2019)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales by Application (2014-2019) (K Units)
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2014-2019)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales by Countries (2014-2019) (K Units)
Table Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries (2014-2019)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Sales Market Share by Countries in 2019
Table Rest of World Opioid Induced Constipation (OIC) Drug Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries (2014-2019)
Figure Rest of World Opioid Induced Constipation (OIC) Drug Revenue Market Share by Countries in 2019
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2014-2019) (K Units)
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Description and Business Overview
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Ironwood Pharmaceuticals Recent Development
Table Daiichi Sankyo Co Company Details
Table Daiichi Sankyo Co Description and Business Overview
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Daiichi Sankyo Co Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Pfizer Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Pfizer Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Description and Business Overview
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Progenics Pharmaceuticals Recent Development
Table Shionogi & Company Details
Table Shionogi & Description and Business Overview
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Shionogi & Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Shionogi & Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Allergan Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Allergan Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Description and Business Overview
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Nektar Therapeutics Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Description and Business Overview
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Purdue Pharma Recent Development
Table S.L.A. Pharma Company Details
Table S.L.A. Pharma Description and Business Overview
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table S.L.A. Pharma Recent Development
Table Mundipharma International Limited Company Details
Table Mundipharma International Limited Description and Business Overview
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2014-2019)
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales Market Share in Global Market
Table Mundipharma International Limited Recent Development
Table Ono Pharmaceutical Company Details
Table Takeda Pharmaceutical Company Limited Company Details
Table Theravance Biopharma Company Details
Table Valeant Pharmaceuticals International Company Details
Table Cosmo Pharmaceuticals SA Company Details
Table Daewoong Pharmaceutical Company Details
Table C.B. Fleet Company Company Details
Table Sucampo Pharmaceuticals Company Details
Figure Opioid Induced Constipation (OIC) Drug Value Chain
Table Opioid Induced Constipation (OIC) Drug Distributors List
Table Opioid Induced Constipation (OIC) Drug Customers List
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Application 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions 2019-2025
Figure United States Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure United States Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure European Union Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure European Union Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure China Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure China Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure Japan Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure Japan Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure Korea Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure Korea Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure India Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure India Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drug Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
- PRICE
-
$3280$6560